Protection without touching the heart:

• The S-ICD System is the first and only subcutaneous implantable defibrillator that shields against SCA without intruding on the heart or vasculature. It utilizes a pulse generator for life-saving therapy delivery, similar to transvenous ICDs, but with a subcutaneous electrode for rhythm analysis, bypassing the need for intracardiac leads.

Effective defibrillation without transvenous leads:

• It boasts impressive capabilities in detecting and converting induced and spontaneous ventricular tachycardia/ventricular fibrillation (VT/VF) episodes, with low rates of significant clinical complications. Additionally, it adeptly discriminates between atrial fibrillation (AF) and supraventricular tachycardia (SVT) from VT/VF, ensuring appropriate therapy delivery.

Sophisticated technology:

• The S-ICD System employs sophisticated algorithms to identify and classify heart rhythm, providing a revolutionary approach to sensing subcutaneous signals. Its INSIGHT™ algorithm effectively distinguishes treatable events from other high-rate supra-ventricular events, allowing for precise therapy delivery.

Durable subcutaneous electrode design:

• With its subcutaneous placement, it avoids intra-cardiac biomechanical stresses, enhancing longevity. The multistrand cable-core design ensures exceptional tensile strength, while the durable polyurethane body resists abrasion, ensuring reliability.

New solution for a broad range of patients at risk for SCA:

• The S-ICD System is effective for a majority of primary and secondary ICD candidates, offering an alternative for TV-ICD replacements due to lead malfunction or infection. It’s particularly suitable for primary electrical or structural heart disease and accommodates a broad range of body types.